Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials Citation: Ferreira JP, Marques P, Anker SD, et al. Diabetes Obes Metab. 2025 Nov 10. Epub ahead of print. PMID: 41208574.
The YODA Project